Our findings that RRS increases CXCL10, granzyme B and Tregs in the early stages of tumor progression may contribute to our understanding of the mechanisms of stress on tumor progression and demonstrate that the use of beta-blockers may serve to reverse the stress-induced impact on the adaptive immune system and mitigate cancer progression. The gene discussed is GZMB; the disease is cancer.